Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q

Stopped "the study has been closed due to a low rate of patient enrollment (2 patients since the start of the trial)"

Conditions

• Myelodysplastic Syndromes

Interventions

• DRUG: Eltrombopag/Revolade
• OTHER: Placebo
• DRUG: Lenalidomide

Sponsor

Associazione Qol-one